Empowered Funds, LLC Nektar Therapeutics Transaction History

Empowered Funds, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 22, 2019	SELL	$30.43 - $56.65 $767,961 - $1.43 Million	-25,237 Closed	0 $0
Q3 2018 Oct 18, 2018	BUY	$46.46 - $68.49 $238,061 - $350,942	5,124 Added 25.48%	25,237 $1.54 Million
Q2 2018 Jul 09, 2018	BUY	$46.25 - $104.45 $271,996 - $614,270	5,881 Added 41.32%	20,113 $969,000
Q1 2018 Apr 25, 2018	BUY	$57.4 - $108.44 $816,916 - $1.54 Million	14,232 New	14,232 $1.5 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $247M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Empowered Funds, LLC, based on Form 13F filings with the SEC.

Stay updated on Empowered Funds, LLC with notifications on news.